JP2004510750A5 - - Google Patents

Download PDF

Info

Publication number
JP2004510750A5
JP2004510750A5 JP2002532258A JP2002532258A JP2004510750A5 JP 2004510750 A5 JP2004510750 A5 JP 2004510750A5 JP 2002532258 A JP2002532258 A JP 2002532258A JP 2002532258 A JP2002532258 A JP 2002532258A JP 2004510750 A5 JP2004510750 A5 JP 2004510750A5
Authority
JP
Japan
Prior art keywords
agonist
ppardelta
activator
ppar delta
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002532258A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004510750A (ja
JP4106263B2 (ja
Filing date
Publication date
Priority claimed from GBGB0024361.8A external-priority patent/GB0024361D0/en
Application filed filed Critical
Publication of JP2004510750A publication Critical patent/JP2004510750A/ja
Publication of JP2004510750A5 publication Critical patent/JP2004510750A5/ja
Application granted granted Critical
Publication of JP4106263B2 publication Critical patent/JP4106263B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002532258A 2000-10-05 2001-10-01 炎症性の状態の治療のためのpparデルタ活性化因子の使用 Expired - Fee Related JP4106263B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024361.8A GB0024361D0 (en) 2000-10-05 2000-10-05 Medicaments
PCT/GB2001/004373 WO2002028434A2 (en) 2000-10-05 2001-10-01 Use of a ppar delta activator for treating inflammatory conditions

Publications (3)

Publication Number Publication Date
JP2004510750A JP2004510750A (ja) 2004-04-08
JP2004510750A5 true JP2004510750A5 (cg-RX-API-DMAC7.html) 2005-12-22
JP4106263B2 JP4106263B2 (ja) 2008-06-25

Family

ID=9900709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002532258A Expired - Fee Related JP4106263B2 (ja) 2000-10-05 2001-10-01 炎症性の状態の治療のためのpparデルタ活性化因子の使用

Country Status (9)

Country Link
US (1) US7084161B2 (cg-RX-API-DMAC7.html)
EP (1) EP1324774B1 (cg-RX-API-DMAC7.html)
JP (1) JP4106263B2 (cg-RX-API-DMAC7.html)
AT (1) ATE318615T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001292046A1 (cg-RX-API-DMAC7.html)
DE (1) DE60117584T2 (cg-RX-API-DMAC7.html)
ES (1) ES2259675T3 (cg-RX-API-DMAC7.html)
GB (1) GB0024361D0 (cg-RX-API-DMAC7.html)
WO (1) WO2002028434A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357914A2 (en) * 2001-02-02 2003-11-05 SmithKline Beecham Corporation Treatment of ppar mediated diseases
JP2004537525A (ja) * 2001-06-11 2004-12-16 メルク エンド カムパニー インコーポレーテッド PPARδアゴニストの投与による炎症性疾患の治療法
IL160845A0 (en) 2001-09-14 2004-08-31 Tularik Inc Linked biaryl compounds
FR2836829B1 (fr) * 2002-03-11 2005-11-25 Bio Merieux Utilisation de l-alpha-lysophosphatidylcholine pour obtenir la differenciation de monocytes en cellules dendritiques matures in vitro
AU2005231358A1 (en) * 2004-04-01 2005-10-20 Aventis Pharmaceuticals Inc. Use of PPR delta agonists for treating demyelinating diseases
ES2352085T3 (es) 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.
WO2005105736A1 (en) 2004-05-05 2005-11-10 Novo Nordisk A/S Novel compounds, their preparation and use
DE602005020313D1 (de) 2004-08-12 2010-05-12 Amgen Inc Bisaryl-sulfonamide
ES2372617T3 (es) 2005-06-30 2012-01-24 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de ppar-delta.
EA201101085A1 (ru) 2005-12-22 2012-05-30 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Феноксиуксусные кислоты в качестве активаторов ppar дельта
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
US20080004281A1 (en) * 2006-06-28 2008-01-03 Kalypsys, Inc. Methods for the modulation of crp by the selective modulation of ppar delta
BRPI0811612A2 (pt) * 2007-05-21 2014-11-11 Senju Pharma Co Composições farmacêuticas que contêm agonista ppardelta
US20110092517A1 (en) * 2009-08-14 2011-04-21 Cerenis Therapeutics S.A. & Nippon Chemiphar Co., Ltd. Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases
KR102038866B1 (ko) * 2012-12-24 2019-10-31 서울대학교산학협력단 PPARδ 활성물질의 항생제, 화상 및 창상 치료제, 당뇨성 족부궤양 치료제로서의 용도
WO2015035171A1 (en) 2013-09-09 2015-03-12 High Point Pharmaceuticals, Llc Use of a ppar-delta agonist for treating muscle atrophy
WO2023147309A1 (en) 2022-01-25 2023-08-03 Reneo Pharmaceuticals, Inc. Use of ppar-delta agonists in the treatment of disease
KR102750722B1 (ko) * 2022-03-16 2025-01-09 재단법인 대구경북첨단의료산업진흥재단 싸이아다이아졸 화합물 및 이를 포함하는 염증성 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1856997A (en) * 1996-02-02 1997-08-22 Merck & Co., Inc. Method for raising hdl cholesterol levels
AU8355998A (en) 1997-07-24 1999-02-16 Yamanouchi Pharmaceutical Co., Ltd. Medicinal compositions with cholesterol-lowering effect
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds

Similar Documents

Publication Publication Date Title
JP2004505105A5 (cg-RX-API-DMAC7.html)
JP4818516B2 (ja) 化合物の抗菌剤としての新規な使用
RU2005135016A (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2006526590A5 (cg-RX-API-DMAC7.html)
AU751235B2 (en) Novel heterocyclic analogs of diphenylethylene compounds
JP2002543065A5 (cg-RX-API-DMAC7.html)
JP2008543854A5 (cg-RX-API-DMAC7.html)
JP2002161074A5 (cg-RX-API-DMAC7.html)
JP2009536178A5 (cg-RX-API-DMAC7.html)
JP2006517939A5 (cg-RX-API-DMAC7.html)
JP2018135343A5 (cg-RX-API-DMAC7.html)
CN1284877A (zh) 胃保护性奥美拉唑微粒、其制备方法及药物制剂
JP2009541387A5 (cg-RX-API-DMAC7.html)
JP2005527576A5 (cg-RX-API-DMAC7.html)
JP2004510749A5 (cg-RX-API-DMAC7.html)
JP2007502817A5 (cg-RX-API-DMAC7.html)
CN1210027C (zh) 治疗溃疡的药物组合物及其应用
JP2005511516A5 (cg-RX-API-DMAC7.html)
JP2005517677A5 (cg-RX-API-DMAC7.html)
JP2005513014A5 (cg-RX-API-DMAC7.html)
JP2007515467A5 (cg-RX-API-DMAC7.html)
JP2005507005A5 (cg-RX-API-DMAC7.html)
JP2004538314A5 (cg-RX-API-DMAC7.html)
CN1681534A (zh) 药物吸收性改善剂
CN1243546C (zh) 不溶于胃液的微粒、其制备方法和药物制剂